172 related articles for article (PubMed ID: 22750227)
1. RANTES, MCP-1 chemokines and factors describing rheumatoid arthritis.
Pavkova Goldbergova M; Lipkova J; Pavek N; Gatterova J; Vasku A; Soucek M; Nemec P
Mol Immunol; 2012 Oct; 52(3-4):273-8. PubMed ID: 22750227
[TBL] [Abstract][Full Text] [Related]
2. Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.
Taylor PC; Peters AM; Paleolog E; Chapman PT; Elliott MJ; McCloskey R; Feldmann M; Maini RN
Arthritis Rheum; 2000 Jan; 43(1):38-47. PubMed ID: 10643698
[TBL] [Abstract][Full Text] [Related]
3. Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Skowronski J; Cylwik JP; Cylwik B; Chwiecko J
J Rheumatol; 2005 Sep; 32(9):1666-72. PubMed ID: 16142858
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.
Cho ML; Min SY; Chang SH; Kim KW; Heo SB; Lee SH; Park SH; Cho CS; Kim HY
Immunol Lett; 2006 Jun; 105(2):159-66. PubMed ID: 16564576
[TBL] [Abstract][Full Text] [Related]
5. Association of polymorphisms in interleukin-10 gene promoter with autoantibody production in patients with rheumatoid arthritis.
Nemec P; Goldbergova MP; Gatterova J; Vasku A; Soucek M
Ann N Y Acad Sci; 2009 Sep; 1173():501-8. PubMed ID: 19758192
[TBL] [Abstract][Full Text] [Related]
6. Relation of IL-6, IL-13 and IL-15 gene polymorphisms to the rheumatoid factors, anti-CCP and other measures of rheumatoid arthritis activity.
Pavkova Goldbergova M; Nemec P; Lipkova J; Jarkovsky J; Gatterova J; Ambrozkova D; Vasku A; Soucek M; Pavek N
Int J Immunogenet; 2014 Feb; 41(1):34-40. PubMed ID: 23773307
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis.
Katschke KJ; Rottman JB; Ruth JH; Qin S; Wu L; LaRosa G; Ponath P; Park CC; Pope RM; Koch AE
Arthritis Rheum; 2001 May; 44(5):1022-32. PubMed ID: 11352233
[TBL] [Abstract][Full Text] [Related]
8. Augmented production of chemokines by the interaction of type II collagen-reactive T cells with rheumatoid synovial fibroblasts.
Min DJ; Cho ML; Lee SH; Min SY; Kim WU; Min JK; Park SH; Cho CS; Kim HY
Arthritis Rheum; 2004 Apr; 50(4):1146-55. PubMed ID: 15077296
[TBL] [Abstract][Full Text] [Related]
9. Etanercept reduces the serum levels of macrophage chemotactic protein-1 in patients with rheumatoid arthritis.
Kageyama Y; Kobayashi H; Kato N; Shimazu M
Mod Rheumatol; 2009; 19(4):372-8. PubMed ID: 19458908
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes.
De Benedetti F; Pignatti P; Bernasconi S; Gerloni V; Matsushima K; Caporali R; Montecucco CM; Sozzani S; Fantini F; Martini A
J Rheumatol; 1999 Feb; 26(2):425-31. PubMed ID: 9972980
[TBL] [Abstract][Full Text] [Related]
11. Coxiella burnetii stimulates production of RANTES and MCP-1 by mononuclear cells: modulation by adhesion to endothelial cells and its implication in Q fever.
Meghari S; Desnues B; Capo C; Grau GE; Raoult D; Mege JL
Eur Cytokine Netw; 2006 Dec; 17(4):253-9. PubMed ID: 17353158
[TBL] [Abstract][Full Text] [Related]
12. Association between RANTES functional polymorphisms and tuberculosis in Hong Kong Chinese.
Chu SF; Tam CM; Wong HS; Kam KM; Lau YL; Chiang AK
Genes Immun; 2007 Sep; 8(6):475-9. PubMed ID: 17625600
[TBL] [Abstract][Full Text] [Related]
13. RANTES and monocyte chemoattractant protein 1 as sensitive markers of disease activity in patients with juvenile rheumatoid arthritis: a six-year longitudinal study.
Yao TC; Kuo ML; See LC; Ou LS; Lee WI; Chan CK; Huang JL
Arthritis Rheum; 2006 Aug; 54(8):2585-93. PubMed ID: 16868981
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus.
Liao CH; Yao TC; Chung HT; See LC; Kuo ML; Huang JL
J Rheumatol; 2004 Oct; 31(10):2062-7. PubMed ID: 15468376
[TBL] [Abstract][Full Text] [Related]
15. MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus.
Lima G; Soto-Vega E; Atisha-Fregoso Y; Sánchez-Guerrero J; Vallejo M; Vargas-Alarcón G; Llorente L
Hum Immunol; 2007 Dec; 68(12):980-5. PubMed ID: 18191726
[TBL] [Abstract][Full Text] [Related]
16. Chemokine MCP1/CCL2 and RANTES/CCL5 gene polymorphisms influence Henoch-Schönlein purpura susceptibility and severity.
Yu HH; Liu PH; Yang YH; Lee JH; Wang LC; Chen WJ; Chiang BL
J Formos Med Assoc; 2015 Apr; 114(4):347-52. PubMed ID: 25839768
[TBL] [Abstract][Full Text] [Related]
17. Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus.
Sánchez E; Sabio JM; Callejas JL; de Ramón E; Garcia-Portales R; García-Hernández FJ; Jiménez-Alonso J; González-Escribano MF; Martín J; Koeleman BP
BMC Med Genet; 2006 May; 7():48. PubMed ID: 16719905
[TBL] [Abstract][Full Text] [Related]
18. Functional polymorphisms in matrix metalloproteinase-1 and monocyte chemoattractant protein-1 and rheumatoid arthritis.
Lee YH; Kim HJ; Rho YH; Choi SJ; Ji JD; Song GG
Scand J Rheumatol; 2003; 32(4):235-9. PubMed ID: 14626631
[TBL] [Abstract][Full Text] [Related]
19. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
[TBL] [Abstract][Full Text] [Related]
20. Association of the -2849 interleukin-10 promoter polymorphism with autoantibody production and joint destruction in rheumatoid arthritis.
Lard LR; van Gaalen FA; Schonkeren JJ; Pieterman EJ; Stoeken G; Vos K; Nelissen RG; Westendorp RG; Hoeben RC; Breedveld FC; Toes RE; Huizinga TW
Arthritis Rheum; 2003 Jul; 48(7):1841-8. PubMed ID: 12847677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
